The Chemours Company $CC Shares Bought by XTX Topco Ltd

XTX Topco Ltd grew its position in shares of The Chemours Company (NYSE:CC) by 358.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 96,604 shares of the specialty chemicals company’s stock after purchasing an additional 75,541 shares during the quarter. XTX Topco Ltd’s holdings in Chemours were worth $1,106,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the company. MTM Investment Management LLC acquired a new stake in shares of Chemours in the 2nd quarter valued at about $27,000. SouthState Corp purchased a new stake in Chemours in the first quarter valued at approximately $34,000. GAMMA Investing LLC boosted its holdings in shares of Chemours by 130.7% in the second quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock valued at $36,000 after acquiring an additional 1,799 shares during the period. Evelyn Partners Asset Management Ltd purchased a new position in shares of Chemours during the second quarter worth approximately $37,000. Finally, FNY Investment Advisers LLC grew its position in shares of Chemours by 100.0% during the second quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock worth $45,000 after acquiring an additional 2,000 shares during the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Royal Bank Of Canada decreased their price target on shares of Chemours from $19.00 to $17.00 and set an “outperform” rating for the company in a research note on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a report on Wednesday, October 8th. UBS Group lowered their price target on Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a report on Tuesday, November 11th. Mizuho dropped their price target on Chemours from $19.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, October 16th. Finally, Truist Financial decreased their price objective on Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Five investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Chemours presently has an average rating of “Hold” and a consensus target price of $17.50.

Chemours Trading Up 2.6%

Shares of Chemours stock opened at $12.79 on Friday. The Chemours Company has a 52-week low of $9.13 and a 52-week high of $22.26. The company has a quick ratio of 0.88, a current ratio of 1.71 and a debt-to-equity ratio of 13.66. The company’s 50-day simple moving average is $13.54 and its 200-day simple moving average is $13.22. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of -5.76 and a beta of 1.64.

Chemours (NYSE:CC) last announced its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The firm had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the previous year, the business earned $0.40 EPS. Chemours’s revenue for the quarter was down .9% on a year-over-year basis. Chemours has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities research analysts anticipate that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Investors of record on Friday, November 14th will be paid a $0.0875 dividend. The ex-dividend date is Friday, November 14th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.7%. Chemours’s payout ratio is -15.77%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.